{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:14:42Z","timestamp":1772705682394,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":1564,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","journals.elsevierhealth.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Molecular Diagnostics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jmoldx.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T13:18:38Z","timestamp":1436361518000},"page":"472-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes"],"prefix":"10.1016","volume":"17","author":[{"given":"Laura J.","family":"Tafe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmoldx.2015.06.001_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jmoldx.2010.11.011","article-title":"Frequency of deletions of EPCAM (TACSTD1) in MSH2-associated Lynch syndrome cases","volume":"13","author":"Rumilla","year":"2011","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1897-4287-11-9","article-title":"Germline deletions in the EPCAM gene as a cause of Lynch syndrome - literature review","volume":"11","author":"Tutlewska","year":"2013","journal-title":"Hered Cancer Clin Pract"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10689-013-9615-1","article-title":"Cancer risk in Lynch Syndrome","volume":"12","author":"Barrow","year":"2013","journal-title":"Fam Cancer"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1373\/clinchem.2013.206888","article-title":"Lynch syndrome presenting as endometrial cancer","volume":"60","author":"Tafe","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1200\/JCO.2014.58.9895","article-title":"Next-generation strategies for hereditary colorectal cancer risk assessment","volume":"33","author":"Yurgelun","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/j.semdp.2014.03.005","article-title":"Role of the clinical pathology laboratory in the evaluation of endometrial carcinomas for Lynch syndrome","volume":"31","author":"Djordjevic","year":"2014","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/gim.2013.166","article-title":"ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis)","volume":"16","author":"Hegde","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jmoldx.2012.03.002","article-title":"ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing","volume":"14","author":"Pritchard","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/01.AOG.0000154885.44002.ae","article-title":"Gynecologic cancer as a \u201csentinel cancer\u201d for women with hereditary nonpolyposis colorectal cancer syndrome","volume":"105","author":"Lu","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/cncr.26323","article-title":"Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries","volume":"118","author":"Ryan","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1756-8722-6-22","article-title":"Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium","volume":"6","author":"Wang","year":"2013","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib12","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1158\/0008-5472.CAN-06-1114","article-title":"Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial carcinoma patients","volume":"66","author":"Hampel","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib13","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/jcp.2009.064949","article-title":"Lynch syndrome (hereditary non-polyposis colorectal cancer) and endometrial carcinoma","volume":"62","author":"Garg","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.gastro.2004.03.068","article-title":"Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance","volume":"127","author":"Hendriks","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib15","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities","volume":"33","author":"Garg","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib16","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humpath.2007.05.022","article-title":"Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer","volume":"39","author":"Shia","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cncr.21560","article-title":"Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma","volume":"106","author":"Broaddus","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib18","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.2010.41","article-title":"Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently under-recognized neoplasms","volume":"6","author":"Tafe","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pgp.0000183048.22588.18","article-title":"Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?","volume":"25","author":"Silva","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib20","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/PAS.0b013e31816380c4","article-title":"Microsatellite instability and mismatch repair protein defects in ovarian epithelial neoplasms in patients 50 year of age or younger","volume":"32","author":"Jensen","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/PGP.0b013e31824fe2aa","article-title":"Prevalence of loss of expression of DNA mismatch repair proteins in primary epithelial ovarian tumors","volume":"31","author":"Lu","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib22","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.1200\/JCO.2008.18.6296","article-title":"Carcinoma of the lower uterine segment: a newly described association with Lynch syndrome","volume":"26","author":"Westin","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib23","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1002\/cncr.28933","article-title":"Performance characteristics of screening strategies for Lynch syndrome in unselected women with newly diagnosed endometrial cancer who have undergone universal germline mutation testing","volume":"120","author":"Ferguson","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib24","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajg.2014.186","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer","volume":"109","author":"Giardiello","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djh034","article-title":"Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability","volume":"96","author":"Umar","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJM199805213382101","article-title":"Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease","volume":"338","author":"Aaltonen","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/GIM.0b013e31818fa2ff","article-title":"Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives","volume":"11","year":"2009","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jmoldx.2011.11.001","article-title":"Relevance, pathogenesis and testing algorithm for mismatch repair-defective colorectal carcinomas: a report of the association for molecular pathology","volume":"14","author":"Funkhouser","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib30","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2012.13088","article-title":"Identification of Lynch syndrome among patients with colorectal cancer","volume":"208","author":"Moreira","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s10897-011-9465-7","article-title":"Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline","volume":"21","author":"Weissman","year":"2012","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib32","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1200\/JCO.2014.58.1322","article-title":"Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines","volume":"33","author":"Stoffel","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gutjnl-2012-304356","article-title":"Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts","volume":"62","author":"Vasen","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2013.51.2129","article-title":"Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing","volume":"32","author":"Buchanan","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib35","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2013.04.022","article-title":"Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center","volume":"130","author":"Moline","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib36","series-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Genetic Familial High-Risk Assessment: Colorectal","year":"2014"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib37","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.2174\/13816128113199990538","article-title":"Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer","volume":"20","author":"Bruegl","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib38","first-page":"5248","article-title":"A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer","volume":"58","author":"Boland","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2353\/jmoldx.2008.080031","article-title":"Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part I. The utility of immunohistochemistry","volume":"10","author":"Shia","year":"2008","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1158\/1940-6207.CAPR-11-0288","article-title":"Identification of cancer patients with Lynch syndrome: clinically significant discordances and problems in tissue-based mismatch repair testing","volume":"5","author":"Bartley","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib41","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1373\/clinchem.2014.227728","article-title":"Feasibility of low-throughput next generation sequencing for germline DNA screening","volume":"60","author":"Sapari","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib42","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s10897-014-9714-7","article-title":"The evolution of cancer risk assessment in the era of next generation sequencing","volume":"23","author":"Fecteau","year":"2014","journal-title":"J\u00a0Genet Couns"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/cge.12028","article-title":"Integrating next-generation sequencing into the diagnostic testing of inherited cancer predisposition","volume":"83","author":"Ku","year":"2013","journal-title":"Clin Genet"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib44","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/gm481","article-title":"Functional DNA quantification guides accurate next-generation sequencing mutation detection in formalin-fixed, paraffin-embedded tumor biopsies","volume":"5","author":"Sah","year":"2013","journal-title":"Genome Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng","year":"2015","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/gim.2013.92","article-title":"ACMG clinical laboratory standards for next-generation sequencing","volume":"15","author":"Rehm","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib47","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/humu.21446","article-title":"Recurrence and variability of germline EPCAM deletions in Lynch syndrome","volume":"32","author":"Kuiper","year":"2011","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib48","doi-asserted-by":"crossref","first-page":"481","DOI":"10.5858\/arpa.2014-0250-CP","article-title":"College of American Pathologists' laboratory standards for next-generation sequencing clinical tests","volume":"139","author":"Aziz","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib49","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jmoldx.2012.04.006","article-title":"Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology","volume":"14","author":"Schrijver","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib50","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/nbt.2403","article-title":"Assuring the quality of next-generation sequencing in clinical laboratory practice","volume":"30","author":"Gargis","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1136\/jmedgenet-2012-101511","article-title":"Refining the role of PMS2 in Lynch syndrome: germline mutational analysis improved by comprehensive assessment of variants","volume":"50","author":"Borr\u00e0s","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/gim.2013.65","article-title":"Three-year experience of a CAP\/ACMG methods-based external proficiency testing program for laboratories offering DNA sequencing for rare inherited disorders","volume":"16","author":"Richards","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib53","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/GIM.0b013e31816b5cae","article-title":"ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007","volume":"10","author":"Richards","year":"2008","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib54","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib55","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2013.73","article-title":"ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing","volume":"15","author":"Green","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/iji.12155","article-title":"Next generation sequencing: considering the ethics","volume":"41","author":"Davey","year":"2014","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bmb\/ldu017","article-title":"Managing the ethical challenges of next-generation sequencing in genomic medicine","volume":"111","author":"Clarke","year":"2014","journal-title":"Br Med Bull"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib58","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ejhg.2014.108","article-title":"To disclose, or not to disclose? Context matters","volume":"23","author":"Rahimzadeh","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib59","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/gim.2014.156","article-title":"The cost-effectiveness of returning incidental findings from next-generation genomic sequencing","volume":"17","author":"Bennette","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib60","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejmg.2013.08.006","article-title":"Disclosing incidental findings in genetics contexts: a review of the empirical ethical research","volume":"56","author":"Christenhusz","year":"2013","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib61","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/humu.22370","article-title":"Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics","volume":"34","author":"Rigter","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib62","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/gim.2013.63","article-title":"Return of incidental findings in genomic medicine: measuring what patients value\u2013development of an instrument to measure preferences for information from next-generation testing (IMPRINT)","volume":"15","author":"Bennette","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib63","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10897-014-9687-6","article-title":"Lynch syndrome patients' views of and preferences for return of results following whole exome sequencing","volume":"23","author":"Hitch","year":"2014","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/gim.2014.151","article-title":"ACMG policy statement: updated recommendations regarding analysis and reporting of secondary findings in clinical genome-scale sequencing","volume":"17","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib65","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrclinonc.2014.169","article-title":"Management of familial cancer: sequencing, surveillance and society","volume":"11","author":"Samuel","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib66","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/gim.2013.37","article-title":"Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies","volume":"15","author":"Goddard","year":"2013","journal-title":"Genet Med"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib67","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PPO.0b013e318262467e","article-title":"Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling","volume":"18","author":"O'Daniel","year":"2012","journal-title":"Cancer J"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib68","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1200\/JCO.2012.45.2789","article-title":"Ethical, legal, and counseling challenges surrounding the return of genetic results in oncology","volume":"31","author":"Lolkema","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib69","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10897-014-9709-4","article-title":"Genetic counselors' views and experiences with the clinical integration of genome sequencing","volume":"23","author":"Machini","year":"2014","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib70","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10897-014-9703-x","article-title":"Genetic counseling practice in next generation sequencing research: implications for the ethical oversight of the informed consent process","volume":"23","author":"Egalite","year":"2014","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib71","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s10897-013-9583-5","article-title":"A closer look at the recommended criteria for disclosing genetic results: perspectives of medical genetic specialists, genomic researchers, and institutional review board chairs","volume":"22","author":"Brandt","year":"2013","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jmoldx.2015.06.001_bib72","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/gim.2014.134","article-title":"Development of a tiered and binned genetic counseling model for informed consent in the era of multiplex testing for cancer susceptibility","volume":"17","author":"Bradbury","year":"2015","journal-title":"Genet Med"}],"container-title":["The Journal of Molecular Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515781500121X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152515781500121X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T12:45:02Z","timestamp":1576241102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152515781500121X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S152515781500121X"],"URL":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.06.001","relation":{},"ISSN":["1525-1578"],"issn-type":[{"value":"1525-1578","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Next-Generation Sequencing for Hereditary Cancer Syndromes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Molecular Diagnostics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmoldx.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}